285 related articles for article (PubMed ID: 21612697)
21. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
22. [Conservative surgery for renal carcinoma].
González Martín M; Alvarez Castelo LM; Chantada Abal V; Rodríguez-Rivera J; Sánchez Merino JM; Gómez Veiga F
Actas Urol Esp; 1999 May; 23(5):424-31. PubMed ID: 10427817
[TBL] [Abstract][Full Text] [Related]
23. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.
Hafez KS; Novick AC; Butler BP
J Urol; 1998 Apr; 159(4):1156-60. PubMed ID: 9507821
[TBL] [Abstract][Full Text] [Related]
24. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
[TBL] [Abstract][Full Text] [Related]
25. Hybrid tumour 'oncocytoma-chromophobe renal cell carcinoma' of the kidney: a report of seven sporadic cases.
Delongchamps NB; Galmiche L; Eiss D; Rouach Y; Vogt B; Timsit MO; Vieillefond A; Méjean A
BJU Int; 2009 May; 103(10):1381-4. PubMed ID: 19154497
[TBL] [Abstract][Full Text] [Related]
26. [Clinical analysis of renal cell carcinoma: report of 271 cases].
Zheng FF; Dai YP; Luo DS; Liang YY; Deng CH; Chen W; Chen LW; Li XF; Qiu SP; Zheng KL
Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(11):829-31. PubMed ID: 19035217
[TBL] [Abstract][Full Text] [Related]
27. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
[TBL] [Abstract][Full Text] [Related]
28. Differences in organ system of distant metastasis by renal cell carcinoma subtype.
Hoffmann NE; Gillett MD; Cheville JC; Lohse CM; Leibovich BC; Blute ML
J Urol; 2008 Feb; 179(2):474-7. PubMed ID: 18076920
[TBL] [Abstract][Full Text] [Related]
29. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
30. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
31. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
[TBL] [Abstract][Full Text] [Related]
32. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
[TBL] [Abstract][Full Text] [Related]
33. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma.
Leibovich BC; Lohse CM; Crispen PL; Boorjian SA; Thompson RH; Blute ML; Cheville JC
J Urol; 2010 Apr; 183(4):1309-15. PubMed ID: 20171681
[TBL] [Abstract][Full Text] [Related]
34. Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis.
Tsuji Y; Goto A; Hara I; Ataka K; Yamashita C; Okita Y; Kamidono S
J Vasc Surg; 2001 Apr; 33(4):789-96. PubMed ID: 11296333
[TBL] [Abstract][Full Text] [Related]
35. [Application of nephron-sparing surgery in the treatment of renal cell carcinoma].
Zhang YS; Li HZ; Ji ZG; Mao ZQ; Rong S; Wang HJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Jun; 31(3):354-7. PubMed ID: 19621524
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
38. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
Carini M; Minervini A; Lapini A; Masieri L; Serni S
J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
[TBL] [Abstract][Full Text] [Related]
39. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
Kim EH; Jain S; Benway BM; Figenshau RS
BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
[TBL] [Abstract][Full Text] [Related]
40. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
Hafez KS; Novick AC; Campbell SC
J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
